InsidersTradesSigma
NantHealth, Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the NantHealth, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, NantHealth, Inc. has published 3 reports. The latest transaction was reported on 30 August 2023 (Acquisition). Among the most active insiders: Louks Ronald Allen. All data is accessible without an account.
3
Insider Decl.
0
Thresholds
€6m
1 ops.
Buy Volume
·
0 ops.
Sell Volume
34Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 August 2023
Declarations3 total
15,384,616 shares@ US$0.39100.0% of flowCommon StockSEC:0000950170-23-045521:0
Ideal exit: 24 May 2024 (T+270)
7,320 shares@ US$0.550141.5% of flowCommon StockSEC:0000899243-21-035924:0
1,505 shares@ US$0.55018.5% of flowCommon StockSEC:0000899243-21-035503:0
3 of 3 declarations
About NantHealth, Inc.
NantHealth, Inc. is a US-listed healthcare technology company historically traded on the NASDAQ (NASDAQ-GS: NH). The company is based in Morrisville, North Carolina, United States, and operates at the intersection of digital healthcare, precision medicine, and payer-provider workflow automation. Its business model is centered on software and SaaS-based solutions sold to health plans, providers, hospitals, and related healthcare organizations. Founded in July 2010, NantHealth emerged from the NantWorks ecosystem with an early vision of combining clinical data, analytics, and interoperability to support more personalized care. Over time, the company has narrowed and sharpened its portfolio around a few core platforms. The best-known product is NaviNet, a payer-provider collaboration network used to support eligibility and benefits, prior authorization, document exchange, referrals, and other administrative workflows. Another core offering is Eviti, an oncology decision-support and treatment validation platform designed to help align care pathways with evidence-based protocols and coverage requirements. NantHealth has also offered data and analytics services, historically including Quadris and related professional services. In addition, the company acquired OpenNMS, an open-source network management platform, which expanded NantHealth’s software footprint beyond healthcare and reinforced its cloud, SaaS, and AI capabilities. From a competitive standpoint, NantHealth operates in a fragmented but demanding market where differentiation depends on interoperability, data security, regulatory compliance, and the ability to reduce administrative friction across the care continuum. The company positions itself as a bridge between complex healthcare data and actionable decision-making, with a focus on helping stakeholders automate processes, improve visibility, and support better patient outcomes. Its customer base is primarily US-centric, although the company has also maintained offices and team presence in locations such as Belfast, Northern Ireland, and other US sites. Recent developments have emphasized product execution and platform monetization. In 2025, NantHealth introduced enhanced NaviNet AllPayer offerings with electronic claim submission functionality, expanding the platform’s value proposition for provider practices and payers. The company has also highlighted ongoing product updates, customer adoption efforts, and continued investment in automation and artificial intelligence. Earlier strategic actions, including asset sales and financing transactions, reflect a broader effort to simplify the portfolio and support liquidity. For investors, NantHealth remains a relatively small-cap US healthcare technology name, with a specialized product set and a risk profile that can be more volatile than that of larger healthcare IT peers.
